Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Parexel Intl Cp (PRXL)

Parexel Intl Cp (PRXL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,502,650
  • Shares Outstanding, K 51,120
  • Annual Sales, $ 2,442 M
  • Annual Income, $ 107,300 K
  • 60-Month Beta 0.79
  • Price/Sales 1.84
  • Price/Cash Flow N/A
  • Price/Book 7.09
Trade PRXL with:
  • Price/Earnings ttm 26.14
  • Earnings Per Share ttm 3.37
  • Most Recent Earnings 0.74 on 05/03/17
  • Next Earnings Date 10/25/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/17
See More
  • Average Estimate 0.89
  • Number of Estimates 8
  • High Estimate 0.96
  • Low Estimate 0.82
  • Prior Year 0.76
  • Growth Rate Est. (year over year) +17.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
87.69 +0.44%
on 09/07/17
88.10 -0.02%
on 09/29/17
+0.30 (+0.34%)
since 08/29/17
3-Month
86.85 +1.42%
on 06/30/17
88.10 -0.02%
on 09/29/17
+1.18 (+1.36%)
since 06/29/17
52-Week
51.16 +72.17%
on 11/11/16
88.10 -0.02%
on 09/29/17
+19.58 (+28.58%)
since 09/29/16

Most Recent Stories

More News
Diabetic Retinopathy Market ,Competitive Landscape, Growth Factors, Revenue Analysis, 2020-2026

Factors contributing to high CAGR are growing prevalence of diabetes along with rising incidence of blindness. Moreover, increase in purchasing power and the dread of losing vision have augmented the expenditure...

ABT : 110.33 (-1.16%)
ALIM : 9.50 (-3.16%)
AMPE : 1.8800 (+5.03%)
NVS : 93.01 (-1.21%)
PRXL : 88.08 (-0.02%)
PFE : 38.81 (-1.70%)
REGN : 537.92 (+0.36%)
VRX.TO : 30.80 (-3.33%)
Diabetic Retinopathy Market Size, Trends and Growth Analysis with Leading Players – Novartis AG, Valeant Pharmaceuticals International Inc., Abbott Laboratories Ltd.

The global was valued at USD 7.39 billion in 2018 and is expected to reach USD 13.04 billion by 2026, at a CAGR of 7.3%. Diabetic retinopathy is a diabetes obstacle that affects eyes. It’s caused by...

ABT : 110.33 (-1.16%)
ALIM : 9.50 (-3.16%)
AMPE : 1.8800 (+5.03%)
NVS : 93.01 (-1.21%)
PRXL : 88.08 (-0.02%)
PFE : 38.81 (-1.70%)
REGN : 537.92 (+0.36%)
VRX.TO : 30.80 (-3.33%)
Global Real-World Evidence Solution Market All Set to Flourish: Expected to Reach worth USD 4,415.3 Million in 2027

According to a study conducted recently by the strategic consulting and market research firm, BlueWeave Consulting, the global real-world evidence (RWE) solution market has reached USD 1.487.1 million...

CLIGF : 11.5631 (unch)
CTSH : 68.32 (-1.23%)
IBM : 143.12 (-1.70%)
PRXL : 88.08 (-0.02%)
PKI : 150.69 (+0.67%)
Global Pharmacovigilance Market Size & Share Will Grow to USD 12.38 Billion by the 2026, according to Facts & Factors

Facts and Factors have published a new research report titled "Pharmacovigilance Market By Service Provider (In-house, and Contract Outsourcing), By Product Life Cycle (Pre-clinical, Phase I, Phase II,...

PRXL : 88.08 (-0.02%)
WIT : 7.84 (-2.61%)
Global Pharmacokinetics Service Market Size Will Reach USD 1,350 Million By 2026: Facts & Factors

Facts and Factors have published a new research report titled "Pharmacokinetics Services Market by Drug Type (Large Molecules and Small Molecules): Global Industry Perspective, Comprehensive Analysis,...

PRXL : 88.08 (-0.02%)
SGSOF : 3,088.0000 (+1.41%)
Diabetic Retinopathy Market Growth, Global Survey, Analysis, Share, Company Profiles and Forecast by 2027

The global Diabetic Retinopathy Market was valued at USD 7.39 billion in 2018 and is expected to reach USD 13.04 billion by 2026, at a CAGR of 7.3%. Diabetic retinopathy is a diabetes obstacle that affects...

ABT : 110.33 (-1.16%)
ALIM : 9.50 (-3.16%)
AMPE : 1.8800 (+5.03%)
NVS : 93.01 (-1.21%)
PRXL : 88.08 (-0.02%)
PFE : 38.81 (-1.70%)
REGN : 537.92 (+0.36%)
VRX.TO : 30.80 (-3.33%)
Thermoplastic Polyester Elastomer (TPEE) Market Growth, Analysis By Recent Trends, Development And Forecast To 2027 | Bayer AG, Pfizer Inc., F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals Inc.

Reports and Data has published a report titled 'Global Thermoplastic Polyester Elastomer (TPEE) Market Forecast to 2026: COVID Impact Analysis,' which gives an in-depth study of the market landscape and...

ABT : 110.33 (-1.16%)
ALIM : 9.50 (-3.16%)
AMPE : 1.8800 (+5.03%)
BAYRY : 15.7300 (-1.47%)
NVS : 93.01 (-1.21%)
PRXL : 88.08 (-0.02%)
PFE : 38.81 (-1.70%)
REGN : 537.92 (+0.36%)
VRX.TO : 30.80 (-3.33%)
Global Clinical Trials Market Report 2020: $28.7 Billion Opportunities to 2025

, /PRNewswire/ -- The report has been added to offering.

PRXL : 88.08 (-0.02%)
SGSOF : 3,088.0000 (+1.41%)
Diabetic retinopathy Market Set for Rapid Growth forecast 2020-2026| Key Players – Bayer AG, Pfizer Inc., F. Hoffmann-La Roche Ltd., and more

The latest updated report on the added by Reports and Data presents a comprehensive analysis of the industry size, revenue forecast, regional spectrum of the business vertical, and further elaborates...

ABT : 110.33 (-1.16%)
ALIM : 9.50 (-3.16%)
AMPE : 1.8800 (+5.03%)
BAYRY : 15.7300 (-1.47%)
NVS : 93.01 (-1.21%)
PRXL : 88.08 (-0.02%)
PFE : 38.81 (-1.70%)
REGN : 537.92 (+0.36%)
VRX.TO : 30.80 (-3.33%)
Diabetic Retinopathy Market 2020-2026 Exhibit A Huge Growth By Profiling Major Companies: Bayer AG, Pfizer Inc., F. Hoffmann-La Roche Ltd., and more

The latest updated report on the added by Reports and Data presents a comprehensive analysis of the industry size, revenue forecast, regional spectrum of the business vertical, and further elaborates...

ABT : 110.33 (-1.16%)
ALIM : 9.50 (-3.16%)
AMPE : 1.8800 (+5.03%)
BAYRY : 15.7300 (-1.47%)
NVS : 93.01 (-1.21%)
PRXL : 88.08 (-0.02%)
PFE : 38.81 (-1.70%)
REGN : 537.92 (+0.36%)
VRX.TO : 30.80 (-3.33%)

Business Summary

Parexel International Corporation is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 88.11
1st Resistance Point 88.10
Last Price 88.08
1st Support Level 88.07
2nd Support Level 88.05
3rd Support Level N/A

See More

52-Week High 88.10
Last Price 88.08
Fibonacci 61.8% 73.99
Fibonacci 50% 69.63
Fibonacci 38.2% 65.27
52-Week Low 51.16

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar